Tyvaso® (treprostinil)
for Pulmonary Arterial Hypertension
Tyvaso (treprostinil) is used to improve exercise capacity in people with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It works by relaxing blood vessels, including those in the lungs, to enhance blood flow. Tyvaso is available as an inhalation solution or dry powder inhaler (DPI) formulation to help manage symptoms and improve exercise ability in patients with these conditions.
